Vicapsys Life Sciences annual operating expenses
2019
2020
2021
2022
2023
Vicapsys Life Sciences Operating Expenses Growth & History (VICP)
Vicapsys Life Sciences's operating expenses was $1.0M for fiscal 2023.
View full Vicapsys Life Sciences company overviewVicapsys Life Sciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $1.0M | $62,188 | +6.31% |
| 2022 | 2022-12-31 | $984,790 | $647,919 | +192.33% |
| 2021 | 2021-12-31 | $336,871 | −$428,973 | −56.01% |
| 2020 | 2020-12-31 | $765,844 | −$268,065 | −25.93% |
| 2019 | 2019-12-31 | $1.0M | — | — |
Vicapsys Life Sciences quarterly operating expenses
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | $198,862 | $23,439 | +13.36% |
| Q2 2024 | 2024-06-30 | $181,841 | $46,148 | +34.01% |
| Q1 2024 | 2024-03-31 | $204,255 | −$7,022 | −3.32% |
| Q4 2023 | 2023-12-31 | $524,585 | $31,979 | +6.49% |
| Q3 2023 | 2023-09-30 | $175,423 | $30,342 | +20.91% |
| Q2 2023 | 2023-06-30 | $135,693 | −$44,363 | −24.64% |
| Q1 2023 | 2023-03-31 | $211,277 | $44,230 | +26.48% |
| Q4 2022 | 2022-12-31 | $492,606 | $388,748 | +374.31% |
| Q3 2022 | 2022-09-30 | $145,081 | $33,900 | +30.49% |
| Q2 2022 | 2022-06-30 | $180,056 | $107,994 | +149.86% |
| Q1 2022 | 2022-03-31 | $167,047 | $117,277 | +235.64% |
| Q4 2021 | 2021-12-31 | $103,858 | $23,309 | +28.94% |
| Q3 2021 | 2021-09-30 | $111,181 | $21,960 | +24.61% |
| Q2 2021 | 2021-06-30 | $72,062 | −$159,553 | −68.89% |
| Q1 2021 | 2021-03-31 | $49,770 | −$314,689 | −86.34% |
| Q4 2020 | 2020-12-31 | $80,549 | −$169,083 | −67.73% |
| Q3 2020 | 2020-09-30 | $89,221 | −$380,119 | −80.99% |
| Q2 2020 | 2020-06-30 | $231,615 | $80,273 | +53.04% |
| Q1 2020 | 2020-03-31 | $364,459 | $200,864 | +122.78% |
| Q4 2019 | 2019-12-31 | $249,632 | — | — |
| Q3 2019 | 2019-09-30 | $469,340 | — | — |
| Q2 2019 | 2019-06-30 | $151,342 | — | — |
| Q1 2019 | 2019-03-31 | $163,595 | — | — |
Vicapsys Life Sciences operating expenses trends
Between the periods ended 2019-12-31 and 2023-12-31, Vicapsys Life Sciences's operating expenses increased from $1.0M to $1.0M, a change of $13,069. The latest reported quarter, Q3 2024, shows $198,862.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicapsys Life Sciences source filings ↗